GMRE
Global Medical REIT Inc.
$35.74
-0.45
(-1.24%)
Mkt Cap
478.13M
Volume
92,285
52W Range
29.05-45.75
Sector
Real Estate
Beta
1.20
EPS (TTM)
-1.36
P/E Ratio
-37.26
Revenue (TTM)
151.68M
Rev Growth (5Y)
+9.6%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
$55.39
Undervalued · Moderate
35.5% below fair value
AlphaQuality · Grade
D
Real Estate Investment Trust
37.5 / 100 composite
Company Description
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 148.21M | 138.41M | 140.93M | 137.17M | 115.80M | 93.52M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380,405 |
| Net Income | (12.12M) | 6.63M | 20.61M | 19.14M | 17.62M | (1.93M) | 9.23M | 13.49M | (38,000) | (6.35M) | (1.61M) | (652,206) |
| EPS | -0.91 | 0.31 | 5.75 | 1.02 | 0.97 | -11.25 | -6.00 | 15.25 | -0.05 | -17.00 | -161.00 | -337.25 |
| Free Cash Flow | 73.61M | (25.07M) | 58.39M | (79.66M) | (132.69M) | (184.27M) | (220.38M) | (156.00M) | (240.62M) | (153.18M) | N/A | N/A |
| FCF / Share | 5.50 | -9.51 | 22.27 | -30.42 | -54.71 | -99.59 | -162.69 | -177.51 | -306.64 | -411.69 | N/A | N/A |
| Operating CF | 73.61M | 70.05M | 68.44M | 76.54M | 68.97M | 34.52M | 36.43M | 24.83M | 11.60M | (2.72M) | N/A | N/A |
| Total Assets | 1.24B | 1.26B | 1.27B | 1.39B | 1.26B | 1.10B | 884.93M | 636.10M | 474.57M | 227.32M | N/A | N/A |
| Total Debt | 0 | 653.59M | 624.19M | 704.65M | 579.86M | 607.62M | 395.06M | 315.01M | 203.44M | 66.53M | N/A | N/A |
| Cash & Equiv | 9.08M | 6.82M | 1.28M | 4.02M | 7.21M | 5.51M | 2.77M | 3.63M | 5.11M | 19.67M | N/A | N/A |
| Book Value | 509.77M | 534.13M | 583.58M | 632.98M | 622.78M | 444.81M | 430.27M | 269.30M | 246.34M | 155.03M | N/A | N/A |
| Return on Equity | -0.02 | 0.01 | 0.04 | 0.03 | 0.03 | -0.00 | 0.02 | 0.05 | -0.00 | -0.04 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.06M | 35.17M | 40.56M | 37.88M | 34.59M | 34.95M | 34.17M | 34.21M | 35.07M | 32.93M | 35.49M | 36.35M |
| Net Income | (749,000) | (11.78M) | (4.55M) | 655,000 | 3.56M | 2.83M | 3.25M | (1.69M) | 2.25M | 616,000 | 4.59M | 13.28M |
| EPS | -0.06 | -0.55 | -0.45 | -0.30 | 0.79 | 0.52 | 0.68 | -1.74 | 0.06 | 0.23 | 1.75 | 4.50 |
| Free Cash Flow | 13.35M | (88.00M) | 92.61M | (18.32M) | (22.32M) | (33.34M) | 21.51M | 15.73M | 12.29M | 14.30M | 13.22M | 15.91M |
| FCF / Share | 1.01 | -6.58 | 6.92 | -6.85 | -8.34 | -12.47 | 8.18 | 5.99 | 4.69 | 5.45 | 5.04 | 6.07 |
| Operating CF | 13.35M | 21.63M | 17.57M | 22.14M | 12.27M | 20.52M | 16.30M | 18.93M | 14.29M | 18.12M | 16.67M | 17.88M |
| Total Assets | 1.24B | 1.24B | 1.27B | 1.30B | 1.27B | 1.26B | 1.24B | 1.24B | 1.26B | 1.27B | 1.30B | 1.32B |
| Total Debt | 0 | 0 | 728.66M | 726.59M | 692.17M | 657.53M | 640.06M | 625.53M | 630.31M | 618.91M | 631.08M | 639.10M |
| Cash & Equiv | 8.18M | 9.08M | 7.12M | 6.58M | 5.41M | 6.82M | 5.72M | 4.98M | 1.33M | 1.28M | 17.47M | 19.51M |
| Book Value | 500.21M | 509.77M | 485.29M | 503.20M | 517.35M | 534.13M | 542.55M | 556.44M | 574.97M | 583.58M | 611.45M | 619.56M |
| Return on Equity | -0.00 | -0.02 | -0.01 | 0.00 | 0.01 | 0.01 | 0.01 | -0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
GMRE News
JPMorgan Chase & Co. Sells 291,977 Shares of Global Medical REIT Inc. $XRN
Analysts Set Global Medical REIT Inc. (NYSE:GMRE) Target Price at $42.00
Reviewing FrontView REIT (NYSE:FVR) and Global Medical REIT (NYSE:GMRE)
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast
Global Medical REIT Inc. (NYSE:GMRE) Receives $41.50 Consensus Price Target from Brokerages
Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.
Global Medical REIT Reports Tax Treatment of 2025 Dividends
Global Medical REIT Inc. Announces Henry Cole Stepping Down from its Board of Directors
Global Medical REIT Inc. $GMRE Position Lessened by Cascade Investment Group Inc.
Analysts Set Global Medical REIT Inc. (NYSE:GMRE) Price Target at $41.50